相关实验视频

Updated: Jul 13, 2025

Minimal Erythema Dose MED Testing

Minimal Erythema Dose MED Testing

Published on: May 28, 2013

细分红多形:对阿纳斯特罗的异常药物反应

Sanja Poduje, Luka Vujević, Nika Filipović¹

¹Nika Filipović, MD, University Hospital Center Sestre Milosrdnice Department of Dermatovenereology, Zagreb, Croatia; nikafilipovic07@gmail.com.

Acta dermatovenerologica Croatica : ADC

|October 16, 2023

概括

用于乳腺癌的阿纳斯托,很少会导致多形红斑 (EM). 本病例报告详细介绍了一例罕见的细分EM局部化到受癌症影响的乳腺,在治疗开始后几个月出现.

科学领域:

皮肤病学皮肤病学
在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

多型红疹 (EM) 是一种免疫介导的粘膜皮肤过敏反应.
作为非选择性芳香酶抑制剂的阿纳斯特,用于乳腺癌的治疗,并已知皮肤副作用.
脑膜炎是一种罕见的阿纳斯托的副作用,通常以主要或轻微的形式呈现,目标病变.

研究的目的:

报告一个罕见的细分红多形病例.
为了突出阿纳斯特罗的罕见皮肤不良影响.
讨论药物爆发的非典型时间.

主要方法:

一个患者的病例报告用阿纳斯特治疗乳腺癌.
罕见皮肤反应的临床观察和记录.
关于阿纳斯特罗诱导的副作用和EM的文献综述.

主要成果:

患者患有局部化的多形细分红血症,局部于受癌症影响的乳腺.
药物爆发发生在开始阿纳斯托治疗几个月后,与典型的表现相反.
这代表了一种极其罕见的皮肤不良影响,仅限于癌症部位.

结论:

细分性多形红疹是一种罕见的阿纳斯托的不良反应.
仅限于癌症影响区域的皮肤反应非常罕见.
在治疗开始数月后,阿纳斯特醇诱导的喷发可能会显现,挑战传统的时间表.

更多相关视频

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging

Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging

Published on: April 8, 2016

相关概念视频

Allergic Drug Reactions

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...

Allergic Reactions

Allergic Reactions